In a recent article published in Nature Communications, researchers discuss 7DW8-5, a glycolipid that utilizes the body's non-specific immune response to quickly combat viral infections, including the ...

Glycolipid metabolic disorders are highly prevalent, cause substantial harm and are independent risk factors for both cardiovascular and cerebrovascular disease. They also play a role in the onset of ...

A recent study posted to the Research Square* preprint server showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including severe acute respiratory ...

As part of the long effort to improve treatment of tuberculosis (TB), microbiologists report that they have for the first time characterized a protein involved in making a glycolipid compound found in ...

The study of liquid crystals and glycolipid phase behaviour addresses the intriguing intersection between soft condensed matter physics and biochemistry. Glycolipids are amphiphilic molecules that can ...

Current interest in glycolipid-based drugs started with work by a Japanese beer company. In the early 1990s, chemists at Kirin Brewery isolated a family of glycolipid natural products called ...

Methicillin-resistant Staphylococcus aureus (MRSA) causes more than 75,000 infections per year in the U.S. In 2011, it had a 14% fatality rate, according to the Centers for Disease Control & ...

Hepatotoxicity in advanced cancer patients receiving immune-based cancer treatment. Preliminary biomarker and pharmacodynamic data from a phase I study of single-agent bispecific antibody T-cell ...